Sleeve lobectomy versus pneumonectomy following neoadjuvant therapy in patients with non-small cell lung cancer.

Meixin TengChengxiang YiWeiguang YangJing ZhangWangchao YaoShiqi HuYang QingShuyu JiZiyun Shen Peng Zhang

Published in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2024)

SL stands as a safe and feasible option for patients with centrally located non-small-cell lung cancer who have undergone neoadjuvant therapy, in comparison to PN. This finding suggests that SL remains the preferable choice when feasible in the context of the widespread utilization of neoadjuvant therapy.

Keyphrases

rectal cancer
locally advanced
lymph node
squamous cell carcinoma
radiation therapy
cell therapy
clinical evaluation